Vitamin D Deficiency as Independent Predictor for Plaque Vulnerability
1 other identifier
observational
332
1 country
1
Brief Summary
Role of vitamin D in cardiovascular disease is controversial. Here the investigators aimed to investigate the association of vitamin D deficiency and carotid plaque morphology as well as outcome of participants with high-grade carotid artery stenosis undergoing carotid endarterectomy. 332 consecutive participants undergoing carotid endarterectomy for symptomatic or asymptomatic carotid artery stenosis, were prospectively included in the study, and vitamin D levels were determined prior to surgery using chemiluminescence-immunoassay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 4, 2024
CompletedFirst Posted
Study publicly available on registry
June 25, 2024
CompletedJune 25, 2024
June 1, 2024
3 years
June 4, 2024
June 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Vitamin D levels and its correlation with plaque vulnerability
Vitamin D levels and its correlation with plaque vulnerability is the primary outcome measurement. Serum 25-hydroxy-vitamin D is measured by the Liaison Total 25-Hydroxy-Vitamin D chemiluminescence immunoassay (CLIA) on Liaison XL immunology analyzers (DiaSorin, Saluggia, Italy.
through study completion, an average of 1 year
Secondary Outcomes (1)
Vitamin D levels and its correlation with cardiac outcome
through study completion, an average of 1 year
Interventions
Serum blood sample for Vitamin D testing
Eligibility Criteria
Patients with carotid arteriosclerosis willing to perform surgery
You may qualify if:
- Carotid arteriostenosis
- Patient eligible for carotid artery surgery
You may not qualify if:
- Oncologic disease
- Patients with hemorrhagic, lacunar or cardioembolic stroke
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of General Surgery, Division of Vascular Surgery
Vienna, 1090, Austria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Christoph Neumayer, MD,Prof.
Medical University of Vienna, Department of General Surgery, Division of Vascular Surgery
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 4, 2024
First Posted
June 25, 2024
Study Start
March 1, 2021
Primary Completion
March 1, 2024
Study Completion
March 1, 2024
Last Updated
June 25, 2024
Record last verified: 2024-06